within Pharmacolibrary.Drugs.ATC.L;

model L01CA06
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 1,
    Cl             = 0.01583333333333333,
    adminDuration  = 600,
    adminMass      = 0.0025,
    adminCount     = 1,
    Vd             = 0.0055,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0,
    Tlag           = 0
  );

  annotation(Documentation(
    info ="<html><body><p>Vintafolide is a folate–drug conjugate developed for targeted cancer therapy, mainly investigated for the treatment of folate receptor-positive solid tumors such as ovarian cancer. It is not currently approved for clinical use after phase III trials failed to meet endpoints.</p><h4>Pharmacokinetics</h4><p>Estimated pharmacokinetic parameters for adult cancer patients, as no published human PK data are available.</p><h4>References</h4><ol><li><p>Lorusso, PM, et al., &amp; Sausville, EA (2012). Phase I study of folate conjugate EC145 (Vintafolide) in patients with refractory solid tumors. <i>Journal of clinical oncology : official journal of the American Society of Clinical Oncology</i> 30(32) 4011–4016. DOI:<a href=&quot;https://doi.org/10.1200/JCO.2011.41.4946&quot;>10.1200/JCO.2011.41.4946</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/23032618/&quot;>https://pubmed.ncbi.nlm.nih.gov/23032618</a></p></li><li><p>Li, J, et al., &amp; LoRusso, P (2009). Clinical pharmacokinetics and exposure-toxicity relationship of a folate-Vinca alkaloid conjugate EC145 in cancer patients. <i>Journal of clinical pharmacology</i> 49(12) 1467–1476. DOI:<a href=&quot;https://doi.org/10.1177/0091270009339740&quot;>10.1177/0091270009339740</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/19837906/&quot;>https://pubmed.ncbi.nlm.nih.gov/19837906</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end L01CA06;
